Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.

International Journal of Dermatology
Ajay N SharmaNatasha Atanaskova Mesinkovska

Abstract

Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off-label use of low-dose oral minoxidil. To conduct a systematic review evaluating the use of oral minoxidil for all types of alopecia. A primary literature search was conducted using PubMed in May 2019, utilizing the search term "oral minoxidil AND (hair loss OR alopecia OR baldness)". Reviews, non-English studies, and articles concerning only topical minoxidil were excluded. Ten articles were included for review comprising a total 19,218 patients (215 women and 19,003 men). Oral minoxidil dose ranged from 0.25 to 5 mg daily to twice daily. The strongest evidence existed for androgenetic alopecia and alopecia areata (AA), with 61-100% and 18-82.4% of patients demonstrating objective clinical improvement. Successful treatment of female pattern hair loss, chronic telogen effluvium, monilethrix, and permanent chemotherapy-induced alopecia was also reported. The most common adverse effects with oral minoxidil included hypertrichosis and postural hypotension. Oral minoxidil is a safe and successful treatment of androgenic alopecia and AA. In addition to its therapeutic benefits, practical advantages over topical minoxidil st...Continue Reading

References

Oct 1, 1988·Clinics in Dermatology·V C Fiedler, C M Buys
Apr 1, 1984·Archives of Dermatology·V C WeissD A Chambers
Dec 1, 1994·International Journal of Dermatology·J Y KooJ E Edwards
Dec 5, 1998·Biopharmaceutics & Drug Disposition·M H AdamsM A Sarkar
Mar 5, 2004·The British Journal of Dermatology·A G Messenger, J Rundegren
Mar 28, 2009·Pharmacotherapy·Lamis R Karaoui, Corinne Chahine-Chakhtoura
May 15, 2015·The Australasian Journal of Dermatology·Xinyi Yang, Keng-Ee Thai
Jun 11, 2016·JAAD Case Reports·Rodney Sinclair
Nov 24, 2017·F1000Research·Eshini Perera, Rodney Sinclair
Mar 23, 2018·The Australasian Journal of Dermatology·William C Cranwell, Rodney Sinclair
Aug 30, 2018·Dermatologic Therapy·Andy Goren, Ty Naccarato
May 6, 2019·Journal of the American Academy of Dermatology·Juan Jimenez-CauheSergio Vaño-Galvan

❮ Previous
Next ❯

Citations

Jan 10, 2021·Journal of the American Academy of Dermatology·Warren R Heymann
Dec 1, 2020·Journal of the American Academy of Dermatology·Baltazar SanabriaPaulo Müller Ramos
Mar 5, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·A VillaniS S Ocampo-Garza
Feb 28, 2021·Journal of the American Academy of Dermatology·Sergio Vañó-GalvánBevin Bhoyrul
Aug 9, 2020·Journal of the American Academy of Dermatology·Dirk M Elston
Aug 18, 2021·Clinical Reviews in Allergy & Immunology·Cheng ZhouJianzhong Zhang
Aug 21, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·R JerjenB Bhoyrul

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Annals of Pharmacotherapy
W M Wong, L Seifert
Journal of the European Academy of Dermatology and Venereology : JEADV
A VillaniS S Ocampo-Garza
American Journal of Clinical Dermatology
Jenna R StoehrStefan Vanderweil
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia
Antonella TostiS Veronesi
© 2022 Meta ULC. All rights reserved